Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022

BUY
$204.81 - $262.19 $271,782 - $347,926
1,327 Added 5.34%
26,191 $5.55 Million
Q2 2022

Aug 03, 2022

BUY
$213.86 - $277.87 $1.25 Million - $1.62 Million
5,834 Added 30.66%
24,864 $5.83 Million
Q1 2022

May 11, 2022

BUY
$259.82 - $298.18 $975,104 - $1.12 Million
3,753 Added 24.57%
19,030 $5.02 Million
Q4 2021

Feb 08, 2022

BUY
$271.6 - $314.21 $1.12 Million - $1.29 Million
4,121 Added 36.94%
15,277 $4.8 Million
Q3 2021

Nov 05, 2021

BUY
$274.82 - $308.34 $142,906 - $160,336
520 Added 4.89%
11,156 $3.14 Million
Q2 2021

Jul 30, 2021

SELL
$251.87 - $278.14 $241,039 - $266,179
-957 Reduced 8.25%
10,636 $2.93 Million
Q1 2021

May 13, 2021

BUY
$204.88 - $255.03 $728,758 - $907,141
3,557 Added 44.26%
11,593 $2.96 Million
Q4 2020

Feb 12, 2021

BUY
$186.91 - $214.42 $1.5 Million - $1.72 Million
8,036 New
8,036 $1.62 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.6B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Distillate Capital Partners LLC Portfolio

Follow Distillate Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Distillate Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Distillate Capital Partners LLC with notifications on news.